Log in to save to my catalogue

Widespread amyloidogenicity potential of multiple myeloma patient-derived immunoglobulin light chain...

Widespread amyloidogenicity potential of multiple myeloma patient-derived immunoglobulin light chain...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a5503dee209f405d8b2875917f0ba3a8

Widespread amyloidogenicity potential of multiple myeloma patient-derived immunoglobulin light chains

About this item

Full title

Widespread amyloidogenicity potential of multiple myeloma patient-derived immunoglobulin light chains

Publisher

England: BioMed Central Ltd

Journal title

BMC biology, 2023-02, Vol.21 (1), p.21-21, Article 21

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

In a range of human disorders such as multiple myeloma (MM), immunoglobulin light chains (IgLCs) can be produced at very high concentrations. This can lead to pathological aggregation and deposition of IgLCs in different tissues, which in turn leads to severe and potentially fatal organ damage. However, IgLCs can also be highly soluble and non-toxi...

Alternative Titles

Full title

Widespread amyloidogenicity potential of multiple myeloma patient-derived immunoglobulin light chains

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a5503dee209f405d8b2875917f0ba3a8

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a5503dee209f405d8b2875917f0ba3a8

Other Identifiers

ISSN

1741-7007

E-ISSN

1741-7007

DOI

10.1186/s12915-022-01506-w

How to access this item